Smoking and Risk of Graves’ Disease

JAMA: The Journal of the American Medical Association

Volumn 269, Issue 4, 1993, Pages 479-482

  Prummel, Mark F ^a,b   Wiersinga, Wilmar M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE PREDISPOSITION; DISEASE SEVERITY; EDUCATION; ETIOLOGY; EYE DISEASE; FEMALE; GRAVES DISEASE; HELPER CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ADULT; AGED; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; GRAVES' DISEASE; HUMAN; MALE; MIDDLE AGE; ODDS RATIO; RISK FACTORS; SMOKING;

EID: 0027534279     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1993.03500040045034     Document Type: Article

References (29)

1. Weetman AP, McGregor AM. Autoimmune thyroid disease: developments in our understanding. Endocr Rev. 1984;5:309-355.
2. McGregor AM. Immunoendocrine interactions and autoimmunity. N Engl J Med. 1990;322:1739-1741.
3. DeGroot LJ, Quintans J. The causes of autoimmune thyroid disease. Endocr Rev. 1989;10:537-562.
4. Ratanachaiyavong S, McGregor AM. Immunogenetics of Graves’ disease. In: Drexhage HA, De Vijlder JJM, Wiersinga WM, eds. The Thyroid Gland, Environment and Autoimmunity. Princeton, NJ: Excerpta Medica; 1990:167-181.
5. Hagg E, Asplund K. Is endocrine ophthalmopathy related to smoking? BMJ. 1987;295:634-635.
6. Angell M. The interpretation of epidemiologic studies. N Engl J Med. 1990;323:823-825.
7. Werner SC. Modification of the classification of the eye changes of Graves’ disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab. 1977; 44:203-204.
8. Berghout A, Wiersinga WM, Drexhage HA, Smits NJ, Touber JL. Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre. Lancet. 1990;336:193-197.
9. Hennekens CH, Buring JE. Case-control studies. In: Hennekens CH, Buring JE, eds. Epidemiology in Medicine. Boston, Mass: Little Brown & Co Inc; 1987:132-152.
10. Prummel MF, Mourits M, Berghout A, et al. Prednisone and cyclosporine in the treatment of severe Graves’ ophthalmopathy. N Engl J Med. 1989; 321:1353-1359.
11. Schlesselman JJ. Basic methods of analysis. In: Schlesselman JJ, ed. Case-Control Studies. New York, NY: Oxford University Press Inc; 1982:171-226.
12. Should we case-control? Lancet. 1990;335:1127-1128.
13. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci. 1989; 34:1841-1854.
14. Christensen SB, Ericsson UB, Janzon L, Tibblin S, Melander A. Influence of cigarette smoking on goiter formation, thyroglobulin, and thyroid hormone levels in women. J Clin Endocrinol Metab. 1984;58:615-618.
15. Statistisch Jaarboek 1990. The Hague, the Netherlands: SDU Publishers; 1990:425.
16. Bartalena L, Martino E, Marcocci C, et al. More on smoking habits and Graves’ ophthalmopathy. J Endocrinol Invest. 1989;12:733-737.
17. Shine B, Fells P, Edwards OM, Weetman AP. Association between Graves’ ophthalmopathy and smoking. Lancet. 1990;335:1261-1263.
18. Shukla R, Kurinczuk JJ. Graves’ ophthalmopathy and smoking. Lancet. 1990;336:184.
19. Hughes DA, Haslam PL, Townsend PJ, Turner-Warwick M. Numerical and functional alterations in circulatory lymphocytes in cigarette smokers. Clin Exp Immunol. 1985;61:459-466.
20. Thomas W, Holt PG, Keast D. Effect of cigarette smoking on primary and secondary humoral responses of mice. Nature. 1973:243:240-241.
21. Volpe R. The role of immune dysregulation in the pathogenesis of autoimmune thyroid disease. In: Drexhage HA, Wiersinga WM, eds. The Thyroid and Autoimmunity. Princeton, NJ: Excerpta Medica; 1986:283-293.
22. Smoking and immunity. Lancet. 1990;335:1561-1563.
23. Fung HYM, Kologlu M, Collison K, et al. Postpartum thyroid dysfunction in Mid Glamorgan. BMJ. 1988;296:241-244.
24. Avila MH, Liang MH, Willett WC, et al. Reproductive factors, smoking, and the risk for rheumatoid arthritis. Epidemiology. 1990;1:285-291.
25. Regius O, Lengyel E, Borzsonnyi L, Beregi E. The effect of smoking on the presence of antinuclear antibodies and the morphology of lymphocytes in aged subjects. Z Gerontol. 1988;21:161-163.
26. Werner SC, Coleman DJ, Franzen LA. Ultrasonographic evidence of a consistent orbital involvement in Graves’ disease. N Engl J Med. 1974;290:1447-1450.
27. Gamblin GT, Harper DG, Galentine P, Buck DR, Chernow B, Eil C. Prevalence of increased intraocular pressure in Graves’ disease: evidence of frequent subclinical ophthalmopathy. N Engl J Med. 1983;308:420-424.
28. Ludgate M, Swillens S, Mercken L, Vassart G. Homology between thyroglobulin and acetylcholinesterase: an explanation for pathogenesis of Graves’ ophthalmopathy? Lancet. 1986:2:219-220.
29. Konishi J, Herman MM, Kriss JP. Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. J Clin Endocrinol Metab. 1974;95:434-446.